KEATON PEAK: Open Payments
NPI 1467017335 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 9 payments from 7 companies in 2025. Trend: 2023 $156 · 2024 $0 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $77 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $43 |
| Endo USA, Inc. | 1 | $26 |
| Procept Biorobotics Corporation | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: REXULTI, WAINUA, ERLEADA, GEMTESA, AVEED, AQUABEAM ROBOTIC SYSTEM, PLUVICTO, ORGOVYX.
Industry payments across AL — which companies pay providers there.
